Lyme disease. 2nd part: Clinical science and treatment;Borréliose de Lyme 2e partie: Clinique et traitement

Revue Medicale Suisse

Volumn 2, Issue 60, 2006, Pages 925-934

  Evison, John ^b   Aebi, Christoph ^b   Francioli, Patrick ^c   Péter, Olivier ^d   Bassetti, Stefano ^e   Gervaix, Alain ^f   Zimmerli, Stefan ^b   Weber, Rainer ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d Laboratoires et Conseils Médicaux SA   (Switzerland)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f Hopital des Enfants Hopitaux universitaires de Geneve   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFTRIAXONE; CEFUROXIME AXETIL; CLARITHROMYCIN; DOXYCYCLINE; PENICILLIN G; ANTIINFECTIVE AGENT;

ACRODERMATITIS; BORRELIA BURGDORFERI; CARDITIS; CHRONIC ARTHRITIS; DOSE RESPONSE; DRUG TOLERANCE; ERYTHEMA CHRONICUM MIGRANS; HUMAN; LABORATORY TEST; LYME DISEASE; LYMPHOCYTOMA; MENINGITIS; POLYMERASE CHAIN REACTION; POLYNEUROPATHY; RADICULITIS; REVIEW; ARTICLE; CLASSIFICATION; DRUG ADMINISTRATION; DRUG COMBINATION; PRACTICE GUIDELINE; PROGNOSIS;

ANTI-BACTERIAL AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; LYME DISEASE; PROGNOSIS;

EID: 33646701171     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Sigal LH. Pitfalls in the diagnosis and management of Lyme disease. Arthritis Rheum 1998;41:195-204.
2. Lyme Borreliose. Deutsche Gesellschaft für pädiatrische Infektiologie. 4. Auflage ed: Futuramed Verlag München; 2003.
3. Constantin C, Peter O, Cerottini J, Derighetti M, Panizzon K, Guggisberg D. Erythema migrans with multiple lesions. Ann Dermatol Venereol 2000;127:513-6.
4. Edlow JA. Erythema migrans. Med Clin North Am 2002;86:239-60.
5. Nahimana I, Gern L, Blanc DS, Praz G, Francioli P, Peter O. Risk of Borrelia burgdorferi infection in western Switzerland following a tick bite. Eur J Clin Microbiol Infect Dis 2004;23:603-8.
6. Nocton JJ, Steere AC. Lyme disease. Adv Intern Med 1995;40:69-117.
7. Hengge UR, Tannapfel A, Tyring SK, Erbel R, Arendt G, Ruzicka T. Lyme borreliosis. Lancet Infect Dis 2003;3: 489-500.
8. Steere AC. Lyme disease. N Engl J Med 2001; 345:115-25.
9. Maraspin V, Cimperman J, Lotric-Furlan S, et al. Solitary borrelial lymphocytoma in adult patients. Wien Klin Wochenschr 2002;114:515-23.
10. Malane MS, Grant-Kels JM, Feder HM, Jr., Luger SW. Diagnosis of Lyme disease based on dermatologic manifestations. Ann Intern Med 1991;114:490-8.
11. Pohl-Koppe A, Wilske B, Weiss M, Schmidt H. Borrelia lymphocytoma in childhood. Pediatr Infect Dis J 1998;17:423-6.
12. Strle F, Pleterski-Rigler D, Stanek G, Pejovnik-Pustinek A, Ruzic E, Cimperman J. Solitary borrelial lymphocytoma: Report of 36 cases. Infection 1992;20:201-6.
13. Halperin JJ. Neuroborreliosis (Nervous System Lyme Disease). Curr Treat Options Neurol 1999;1:139-46.
14. Kaiser R. Neuroborreliosis. J Neurol 1998;245:247-55.
15. Maraspin V, Cimperman J, Lotric-Furlan S, Ruzic-Sabljic E, Jurca T, Strle F. Cerebrospinal fluid findings in adult patients with multiple erythema migrans. Wien Klin Wochenschr 2002;114:505-9.
16. Garcia-Monco JC, Benach JL. Lyme neuroborreliosis. Ann Neurol 1995;37:691-702.
17. Lotric-Furlan S, Cimperman J, Maraspin V, et al. Lyme borreliosis and peripheral facial palsy. Wien Klin Wochenschr 1999;111:970-5.
18. Albisetti M, Schaer G, Good M, Bohsnauser E, Nadal D. Diagnostic value of Cerebrospinal fluid examination in children with peripheral facial palsy and suspected Lyme borreliosis. Neurology 1997;49:817-24.
19. Pinto DS. Cardiac manifestations of Lyme disease. Med Clin North Am 2002;86:285-96.
20. Cox J, Krajden M. Cardiovascular manifestations of Lyme disease. Am Heart J 1991;122:1449-55.
21. Nagi KS, Joshi R, Thakur RK. Cardiac manifestations of Lyme disease:A review. Can J Cardiol 1996;12:503-6.
22. Sonnesyn SW, Diehl SC, Johnson RC, Kubo SH, Goodman JL. A prospective study of the seroprevalence of Borrelia burgdorferi infection in patients with severe heart failure. Am J Cardiol 1995;76:97-100.
23. Lardieri G, Salvi A, Camerini F, Cinco M, Trevisan G. Isolation of Borrelia burgdorferi from myocardium. Lancet 1993;342:490.
24. Gasser R, Dusleag J, Fruhwald F, Klein W, Reisinger E. Early antimicrobial treatment of dilated cardiomyopathy associated with Borrelia burgdorferi. Lancet 1992; 340:982.
25. Bartunek P, Mrazek V, Gorican K, Bina R, Listvanova S, Zapletalova J. Borrelia infection as a cause of carditis (a long-term study). Wien Klin Wochenschr 2001;113: 38-44.
26. Christen HJ, Hanefeld F, Eiffert H, Thomssen R. Epidemiology and clinical manifestations of Lyme borreliosis in childhood. A prospective multicentre study with special regard to neuroborreliosis. Acta Paediatr Suppl 1993;386:1-75.
27. Gerber MA, Shapiro ED, Burke GS, Parcells VJ, Bell GL. Lyme disease in children in southeastern Connecticut Pediatric Lyme Disease Study Group. N Engl J Med 1996;335:1270-4.
28. Steere AC, Batsford WP, Weinberg M, et al. Lyme carditis: Cardiac abnormalities of Lyme disease. Ann Intern Med 1980;93:8-16.
29. McAlister HF, Klementowicz PT, Andrews C, Fisher JD, Feld M, Furman S. Lyme carditis:An important cause of reversible heart block. Ann Intern Med 1989;110: 339-45.
30. Sood SK. Lyme disease. Pediatr Infect Dis J 1999;18: 913-25.
31. Sigal LH. Musculoskeletal manifestations of Lyme arthritis. Rheum Dis Clin North Am 1998;24:323-51.
32. Massarotti EM. Lyme arthritis. Med Clin North Am 2002;86:297-309.
33. Steere AC, Schoen RT, Taylor E. The clinical evolution of Lyme arthritis. Ann Intern Med 1987;107:725-31.
34. Nadelman RB, Wormser GP. Lyme borreliosis. Lancet 1998;352:557-65.
35. Stanek G, Strle F. Lyme borreliosis. Lancet 2003; 362:1639-47.
36. Steere AC, Levin RE, Molloy PJ, et al. Treatment of Lyme arthritis. Arthritis Rheum 1994;37:878-88.
37. Bentas W, Karch H, Huppertz HI. Lyme arthritis in children and adolescents: Outcome 12 months after initiation of antibiotic therapy. J Rheumatol 2000;27: 2025-30.
38. Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 1994;330: 229-34.
39. Ostrov BE, Athreya BH. Lyme disease. Difficulties in diagnosis and management Pediatr Clin North Am 1991; 38:535-53.
40. Nadal D, Gundelfinger R, Flueler U, Boltshauser E. Acrodermatitis chronica atrophicans. Arch Dis Child 1988;63:72-4.
41. Coblyn JS, Taylor P. Treatment of chronic Lyme arthritis with hydroxychloroquine. Arthritis Rheum 1981; 24:1567-9.
42. Schoen RT, Aversa JM, Rahn DW, Steere AC. Treatment of refractory chronic Lyme arthritis with arthroscopic synovectomy. Arthritis Rheum 1991;34:1056-60.
43. Huppertz HI. Lyme disease in children. Curr Opin Rheumatol 2001;13:434-40.
44. Prasad A, Sankar D. Overdiagnosis and overtreatment of Lyme neuroborreliosis are preventable. Postgrad Med J 1999;75:650-6.
45. Reid MC, Schoen RT, Evans J, Rosenberg JC, Horwitz RI. The consequences of overdiagnosis and overtreatment of Lyme disease: An observational study. Ann Intern Med 1998;128:354-62.
46. Steers AC, Taylor E, McHugh GL, Logigian EL. The overdiagnosis of Lyme disease. JAMA 1993;269:1812-6.
47. Qureshi MZ, New D, Zulqarni NJ, Nachman S. Overdiagnosis and over-treatment of Lyme disease in children. Pediatr Infect Dis J 2002;21:12-4.
48. Wormser GP, Ramanathan R, Nowakowski J, et al. Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2003;138:697-704.
49. Steere AC. Duration of antibiotic therapy for Lyme disease. Ann Intern Med 2003;138:761-2.
50. Strle F, Nadelman RB, Cimperman J, et al. Comparison of culture-confirmed erythema migrans caused by Borretia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. Ann Intern Med 1999; 130:32-6.
51. Dattwyler RJ, Luft BJ, Kunkel MJ, et al. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. N Engl J Med 1997;337:289-94.
52. Shadick NA, Phillips CB, Logigian EL, Steere AC, Kaplan RF, Berardl VP, et al. The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med 1994;121:560-7.
53. Berglund J, Stjernberg L, Ornstein K, Tykesson-Joelsson K, Walter H. 5-y Follow-up study of patients with neuroborreliosis. Scand J Infect Dis 2002;34:421-5.
54. Nadelman RB, Nowakowski J, Fish D, et al. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med 2001;345:79-84.
55. Ettestad PJ, Campbell GL, Welbel SF, et al. Biliary complications in the treatment of unsubstantiated Lyme disease. J Infect Dis 1995;171:356-61.
56. Patel R, Grogg KL, Edwards WD, Wright AJ, Schwenk NM. Death from inappropriate therapy for Lyme disease. Clin Infect Dis 2000;31:1107-9.
57. Stanek G, O'Connell S, Cimmino M, et al. European Union Concerted Action on Risk Assessment in Lyme Borreliosis: Clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 1996;108:741-7.
58. Wormser GP, Nadelman RB, Dattwyler RJ, et al. Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America. Clin Infect Dis 2000;31(Suppl. 1):1-14.